| GTO ID | GTC2534 |
| Trial ID | NCT04665063 |
| Disease | Hodgkin's Lymphoma |
| Therapy | CAR-T cell |
| Treatment | Auto CAR-T |
| Recruitment status | Recruiting |
| Title | A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Hebei Senlang Biotechnology Inc., Ltd. |
| Other ID(s) | 2020103 |
| Cohort 1 | |||||||||||
|
|||||||||||